Elevance Health, Inc. $ELV Shares Purchased by Greatmark Investment Partners Inc.

Greatmark Investment Partners Inc. raised its holdings in Elevance Health, Inc. (NYSE:ELV) by 23.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 35,483 shares of the company’s stock after acquiring an additional 6,833 shares during the quarter. Elevance Health accounts for about 1.4% of Greatmark Investment Partners Inc.’s portfolio, making the stock its 24th biggest holding. Greatmark Investment Partners Inc.’s holdings in Elevance Health were worth $11,465,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Vermillion & White Wealth Management Group LLC raised its holdings in shares of Elevance Health by 94.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after purchasing an additional 37 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new position in shares of Elevance Health in the second quarter valued at $32,000. Glass Jacobson Investment Advisors llc increased its holdings in shares of Elevance Health by 400.0% in the second quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock valued at $39,000 after buying an additional 80 shares in the last quarter. Motco lifted its position in shares of Elevance Health by 334.8% during the 3rd quarter. Motco now owns 100 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the last quarter. Finally, Trust Co. of Toledo NA OH acquired a new position in shares of Elevance Health in the 2nd quarter worth $43,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Elevance Health Price Performance

NYSE ELV opened at $370.77 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56. The firm has a market capitalization of $82.40 billion, a price-to-earnings ratio of 15.16, a price-to-earnings-growth ratio of 1.91 and a beta of 0.51. The company has a 50 day simple moving average of $349.17 and a 200-day simple moving average of $328.79. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $458.75.

Analysts Set New Price Targets

ELV has been the subject of several analyst reports. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $431.00 target price on shares of Elevance Health in a report on Tuesday, January 6th. Robert W. Baird upped their price objective on shares of Elevance Health from $297.00 to $340.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. The Goldman Sachs Group assumed coverage on shares of Elevance Health in a report on Tuesday, October 14th. They issued a “neutral” rating and a $343.00 target price for the company. Wall Street Zen lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a report on Saturday, December 13th. Finally, Guggenheim raised their price objective on shares of Elevance Health from $398.00 to $414.00 and gave the stock a “buy” rating in a research note on Thursday. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $399.63.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.